Emergent Biosolutions Inc (EBS) Insider Trading
- $112,380.00
- $132,779,560.92
- June 4, 2024
- Fuad El-Hibri
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 4, 2024 | Director | 10,000 | $6.11 | Sell | $61,100.00 | |
May 29, 2024 | Director | 1,830 | $4.61 | Sell | $8,436.30 | |
May 21, 2024 | Director | 1,089 | $5.78 | Sell | $6,294.42 | |
Nov. 25, 2022 | Director | 1,912 | $11.94 | Sell | $22,829.28 | |
May 24, 2022 | Director | 1,996 | $35.53 | Sell | $70,917.88 | |
Nov. 15, 2021 | CFO | 3,000 | $37.46 | Buy | $112,380.00 | |
May 25, 2021 | Director | 3,139 | $56.48 | Sell | $177,290.72 | |
March 4, 2021 | Director | 8,168 | $92.37 | Sell | $754,478.16 | |
Jan. 21, 2021 | CEO | 21,900 | $110.03 | Sell | $2,409,657.00 | |
Jan. 15, 2021 | CEO | 19,026 | $106.01 | Sell | $2,016,946.26 | |
Nov. 2, 2020 | Chairman | 20,000 | $90.44 | Sell | $1,808,800.00 | |
Sept. 24, 2020 | Major Shareholder | 25,535 | $99.73 | Sell | $2,546,605.55 | |
Sept. 16, 2020 | Chairman | 20,000 | $102.48 | Sell | $2,049,600.00 | |
Sept. 10, 2020 | Major Shareholder | 40,000 | $102.73 | Sell | $4,109,200.00 | |
Sept. 2, 2020 | Director | 28,418 | $111.22 | Sell | $3,160,649.96 | |
Aug. 17, 2020 | Director | 6,609 | $133.71 | Sell | $883,689.39 | |
Aug. 11, 2020 | Director | 6,000 | $124.11 | Sell | $744,660.00 | |
June 3, 2020 | Director | 6,572 | $87.51 | Sell | $575,115.72 | |
May 11, 2020 | Director | 4,940 | $81.99 | Sell | $405,030.60 | |
May 5, 2020 | Director | 8,375 | $80.19 | Sell | $671,591.25 | |
April 29, 2020 | Chairman | 20,000 | $74.24 | Sell | $1,484,800.00 | |
April 27, 2020 | Director | 7,893 | $78.00 | Sell | $615,654.00 | |
April 22, 2020 | Chairman | 20,000 | $66.81 | Sell | $1,336,200.00 | |
April 20, 2020 | EVP | 17,009 | $69.00 | Sell | $1,173,621.00 | |
April 17, 2020 | EVP | 20,414 | $65.00 | Sell | $1,326,910.00 | |
April 15, 2020 | Chairman | 12,537 | $62.58 | Sell | $784,565.46 | |
April 13, 2020 | Chairman | 17,071 | $62.25 | Sell | $1,062,669.75 | |
April 8, 2020 | Chairman | 37,362 | $61.13 | Sell | $2,283,939.06 | |
April 6, 2020 | EVP | 7,972 | $60.00 | Sell | $478,320.00 | |
April 6, 2020 | Chairman | 28,240 | $60.50 | Sell | $1,708,520.00 | |
March 16, 2020 | Director | 6,400 | $65.00 | Sell | $416,000.00 | |
March 4, 2020 | Director | 991 | $60.65 | Sell | $60,104.15 | |
Feb. 26, 2020 | Chairman | 13,619 | $58.70 | Sell | $799,435.30 | |
Feb. 20, 2020 | Chairman | 4,751 | $64.90 | Sell | $308,339.90 | |
Feb. 18, 2020 | Chairman | 15,614 | $63.90 | Sell | $997,734.60 | |
Feb. 14, 2020 | Chairman | 4,386 | $63.90 | Sell | $280,265.40 | |
Feb. 12, 2020 | Chairman | 13,720 | $62.90 | Sell | $862,988.00 | |
Feb. 5, 2020 | Chairman | 48,316 | $60.66 | Sell | $2,930,848.56 | |
Jan. 16, 2020 | Director | 3,435 | $55.00 | Sell | $188,925.00 | |
Dec. 12, 2019 | Director | 8,375 | $53.46 | Sell | $447,727.50 | |
Nov. 18, 2019 | Director | 1,000 | $54.06 | Sell | $54,060.00 | |
Nov. 8, 2019 | Director | 3,082 | $54.15 | Sell | $166,890.30 | |
Sept. 9, 2019 | Director | 1,509 | $56.12 | Sell | $84,685.08 | |
May 28, 2019 | Director | 1,376 | $43.39 | Sell | $59,704.64 | |
March 11, 2019 | EVP | 2,430 | $56.93 | Sell | $138,339.90 | |
March 4, 2019 | CEO | 14,565 | $58.11 | Sell | $846,372.15 | |
March 1, 2019 | EVP | 3,043 | $58.11 | Sell | $176,828.73 | |
Feb. 28, 2019 | Chairman | 27,725 | $58.83 | Sell | $1,631,061.75 | |
Feb. 26, 2019 | Chairman | 10,369 | $59.65 | Sell | $618,510.85 | |
Nov. 27, 2018 | Director | 17,717 | $69.62 | Sell | $1,233,457.54 |
Insiders are both buying and selling Emergent Biosolutions Inc stock.
The insider traders at Emergent Biosolutions Inc are: Fuad El-Hibri, Adam Havey, Ronald Richard, Daniel Abdun-Nabi, Kathryn C Zoon, Zsolt Harsanyi, Robert Kramer, Sue Bailey, Jerome M Hauer, George A Joulwan, Louis W Sullivan, Barry Labinger, Marvin L White, and Richard S Lindahl
The most active insider trader at Emergent Biosolutions Inc is Fuad El-Hibri with 55 trades.
Fuad El-Hibri has sold the most Emergent Biosolutions Inc stock with a total value of $71,606,733.69.
Richard S Lindahl has bought the most Emergent Biosolutions Inc stock with a total value of $224,760.00.
The most recent insider trade for Emergent Biosolutions Inc was on June 4, 2024.
The single biggest insider buy for Emergent Biosolutions Inc was from Richard S Lindahl with a total value of $112,380.00 on Nov. 15, 2021.
The single biggest insider sell for Emergent Biosolutions Inc was from Daniel Abdun-Nabi with a total value of $5,462,899.68 on Sept. 5, 2018.